{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:01:40Z","timestamp":1789016500502,"version":"build-2803163510"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,8]]},"DOI":"10.18632\/oncotarget.11866","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T22:30:53Z","timestamp":1473201053000},"page":"73448-73461","source":"Crossref","is-referenced-by-count":17,"title":["Low-dose salinomycin induces anti-leukemic responses in AML and MLL"],"prefix":"10.18632","volume":"7","author":[{"given":"Gary D.R.","family":"Roulston","sequence":"first","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Burt","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.J.","family":"Kettyle","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle B.","family":"Matchett","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Keenan","sequence":"additional","affiliation":[{"name":"Cambridge University School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, CB2 0SP, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuala M.","family":"Mulgrew","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoifa","family":"Dougan","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McKiernan","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan V.","family":"Grishagin","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken I.","family":"Mills","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thompson","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT9 7AE, Northern Ireland, United Kingdom"},{"name":"Division of Cancer and Stem Cells, School of Medicine, Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), University of Nottingham, Nottingham, NG7 2RD, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"1","first-page":"442","article-title":"The Repurposing Drugs in Oncology (ReDO) Project","volume":"8","author":"Vikas","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nrd3405","article-title":"The productivity crisis in pharmaceutical R&D","volume":"10","author":"Riccaboni","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Rosenthal","year":"2014","journal-title":"Nat Biotechnol"},{"key":"4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/clpt.2010.286","article-title":"Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009","volume":"89","author":"DiMasi","year":"2011","journal-title":"Clin Pharmacol Therapeutics"},{"key":"5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Ward","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","article-title":"Global cancer patterns: causes and prevention","volume":"383","author":"Wild","year":"2014","journal-title":"Lancet"},{"key":"7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Lander","year":"2009","journal-title":"Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.2174\/15672050113109990199","article-title":"Salinomycin: a novel anti-cancer agent with known anti-coccidial activities","volume":"20","author":"Wu","year":"2013","journal-title":"Curr Med Chem"},{"key":"9","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/stem.1398","article-title":"Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia","volume":"31","author":"Krosl","year":"2013","journal-title":"Stem Cells"},{"key":"10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0006-291X(75)90490-8","article-title":"Salinomycin: a new monovalent cation ionophore","volume":"66","author":"Miyazaki","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/AAC.9.4.655","article-title":"Salinomycin effects on mitochondrial ion translocation and respiration","volume":"9","author":"Otake","year":"1976","journal-title":"J Antimicrob Agents Chemother"},{"key":"12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2009.10.042","article-title":"Salinomycin induces apoptosis, overcomes apoptosis resistance in human cancer cells","volume":"390","author":"Naujokat","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.2010.01089.x","article-title":"Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein","volume":"162","author":"Yoon","year":"2011","journal-title":"Br J Pharmacol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10637-011-9685-6","article-title":"Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest","volume":"30","author":"Yoon","year":"2012","journal-title":"Invest New Drugs"},{"key":"15","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1073\/pnas.1110431108","article-title":"Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Carson","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"16","first-page":"318","article-title":"The comparative toxicology of narasin in laboratory animals","volume":"36","author":"Todd","year":"1994","journal-title":"Vet Hum Toxicol"},{"key":"17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/104063879500700327","article-title":"Acute salinomycin toxicosis of pigs","volume":"7","author":"Galey","year":"1995","journal-title":"Vet Diagn Invest"},{"key":"18","first-page":"U799","article-title":"A case of human poisoning by salinomycin, an agricultural antibiotic","volume":"117","author":"Doube","year":"2004","journal-title":"NZ Med J"},{"key":"19","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Montojo","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"von Mering","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources","volume":"4","author":"Lempicki","year":"2009","journal-title":"Nature Protoc"},{"key":"22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Lempicki","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ygyno.2014.10.011","article-title":"Old drug, new trick: repurposing metformin for gynecologic cancers?","volume":"135","author":"Romero","year":"2014","journal-title":"Gynecolog oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.toxlet.2013.02.001","article-title":"Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro","volume":"218","author":"Kleinsasser","year":"2013","journal-title":"Toxicology Letters"},{"key":"25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.tiv.2015.01.018","article-title":"Geno- and cytotoxicity of salinomycin in human nasal mucosa and peripheral blood lymphocytes","volume":"29","author":"Kleinsasser","year":"2015","journal-title":"Toxicology in Vitro"},{"key":"26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/bjc.2011.530","article-title":"Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress","volume":"106","author":"Lljin","year":"2012","journal-title":"Br J Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Jhansen","year":"2007","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.bbamcr.2013.04.011","article-title":"Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells","volume":"1833","author":"\u0141os","year":"2013","journal-title":"Biochimica et biophysica acta"},{"key":"29","first-page":"604","article-title":"Monitoring of autophagy is complicated-salinomycin as an example","volume":"1853","author":"\u0141os","year":"2014","journal-title":"Biochim et biophys acta"},{"key":"30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/auto.24632","article-title":"Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells","volume":"9","author":"Liu","year":"2013","journal-title":"Autophagy"},{"key":"31","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1074\/jbc.M109.039925","article-title":"Nucleocytoplasmic shuttling of p62\/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies","volume":"285","author":"Johansen","year":"2010","journal-title":"J Biol Chem"},{"key":"32","first-page":"1","article-title":"Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches","volume":"1","author":"Introna","year":"2015","journal-title":"Leukemia"},{"key":"33","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/leu.2014.108","article-title":"The targeting of immunosuppressive mechanisms in hematological malignancies","volume":"9","author":"Andersen","year":"2014","journal-title":"Leukemia"},{"key":"34","first-page":"921","article-title":"CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression","volume":"6","author":"Morishita","year":"2011","journal-title":"Leukemia"},{"key":"35","first-page":"918","article-title":"The role of TLR8 signaling in acute myeloid leukemia differentiation","volume":"4","author":"Wald","year":"2015","journal-title":"Leukemia"},{"key":"36","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/leu.2014.46","article-title":"A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib","volume":"28","author":"Anderson","year":"2014","journal-title":"Leukemia"},{"key":"37","first-page":"157","article-title":"Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling","volume":"1","author":"Heuser","year":"2015","journal-title":"Leukemia"},{"key":"38","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.18632\/oncotarget.3278","article-title":"Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"39","first-page":"41","article-title":"Mitochondrial dependency in progression of acute myeloid leukemia","volume":"21C","author":"Banerjee","year":"2015","journal-title":"Mitochondrion"},{"key":"40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Bartoszko","year":"2011","journal-title":"Cancer Cell"},{"key":"41","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Lin","year":"2015","journal-title":"Blood"},{"key":"42","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.18632\/oncotarget.2433","article-title":"The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer","volume":"5","author":"Nelson","year":"2014","journal-title":"Oncotarget"},{"key":"43","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.18632\/oncotarget.3585","article-title":"Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the \u03b2-catenin\/TCF complex association via FOXO3a activation","volume":"6","author":"Liang","year":"2015","journal-title":"Oncotarget"},{"key":"44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0167-7799(03)00004-0","article-title":"A new science-business paradigm in anticancer drug development","volume":"21","author":"Blagosklonny","year":"2003","journal-title":"Trends Biotechnol"},{"key":"45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/cbt.27309","article-title":"HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells","volume":"15","author":"Dent","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-015-3376-5","article-title":"Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin","volume":"151","author":"Chen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"47","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood-2009-04-216606","article-title":"Leukemogenic transformation by HOXA cluster genes","volume":"115","author":"Slany","year":"2010","journal-title":"Blood"},{"key":"48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V99.1.121","article-title":"Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion","volume":"99","author":"Sauvageau","year":"2002","journal-title":"Blood"},{"key":"49","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/bioinformatics\/btm311","article-title":"beadarray: R classes and methods for Illumina bead-based data","volume":"23","author":"Tavar\u00e9","year":"2007","journal-title":"Bioinformatics"},{"key":"50","unstructured":"Dunning, Lynch, Eldridge. illuminaMousev2.db: Illumina MouseWG6v2 annotation data (chip illuminaMousev2). R package version 1.24.0."},{"key":"51","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Smyth","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:57:56Z","timestamp":1589291876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":52,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2016,11,8]]}},"alternative-id":["11866","27612428"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11866","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}